Rep. Chris Smith (R-NJ), Co-Chair of the House Pro-Life Caucus, issued the following statement in response to the Supreme Court’s ruling in FDA v. Alliance for Hippocratic Medicine that fails to protect women and their unborn children from the harms of chemical abortion:

            “The Supreme Court’s failure to recognize the standing of the brave doctors who care for the women and girls harmed by the FDA’s unlawful removal of safety regulations for the drug mifepristone is deeply disappointing.

            The Alliance Defending Freedom did a magnificent job representing these courageous physicians. Despite the Court’s decision to not consider the case for now, we know that the fight for transparent care that prioritizes the health and safety of women continues as at least three states—Idaho, Kansas, and Missouri—have already sought to challenge the FDA’s malpractice.

            In addition to killing an unborn child by starving the baby to death—an outrage in and of itself—the chemical abortion regimen presents significant health risks to pregnant women, which the FDA has recklessly and shamefully ignored.

            According to the FDA’s own label on mifepristone, 1 out of 25 women who take mifepristone will need emergency care. The real number of women experiencing severe bleeding, life-threatening infection, and undiagnosed ectopic pregnancy may be much higher, but the FDA conveniently fails to collect comprehensive safety data while making unsupported claims that mifepristone is safe.

            Beginning with President Clinton, the FDA—supposedly our gatekeeper for drug safety— has actively promoted the abortion poison/baby starvation pill and has failed to strictly adhere to its own testing protocols.

            The FDA must be held accountable for enabling the abortion industry to prey on women and girls during their most vulnerable moments of need.”

###